2024-510765-42-00CompletedPhase 1
A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 17 May 2024
- Start date
- 1 Oct 2024
- Lead sponsor
- Bayer AG
- EU CT number
- 2024-510765-42-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 8
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.